National and Kapodistrian University of Athens
Επιδημιολογική κλινικοεργαστηριακή και θεραπευτική μελέτη των ουρολοιμώξεων σε ασθενείς με απομυελινωτική νόσο
Abstract
dc:descriptionObjective: We studied clinical and laboratory findings of patients with multiple sclerosis (MS) and associated bladder dysfunction. We also aimed to examine rates of asymptomatic bacteriuria and symptomatic urinary tract infection (UTI) in this patient population, according to whether they were using self intermittent catheterization (SIC). Also, we determined the effects of long term antimicrobial prophylaxis as well as possible predictors of failure.Design: The study included 167 patients with a definite diagnosis of MS and bladder dysfunction. Epidimiological, clinical and laboratory findings were evaluated. Patients were categorized in 3 groups, according to post-voided residual urine volume (PVR): patients with indications for SIC who elected (Group A, n=39) or not (Group B, n=53) to use SIC and patients with no indication for SIC (Group C, n=75). Urine cultures were taken at baseline and monthly thereafter up to 6 months. Patients with bacteriuria were placed on long term prophylaxis with nitrofurantoin 100 mg qd after eradication of bacteriuria. If bacteriuria recurred, prophylaxis with norfloxacin 400 mg qd was given after eradication of bacteriuria. Rates of recurrent asymptomatic bacteriuria and symptomatic UTIs were assessed during follow-up.Results: A statistical significant association was found between the severity of bladder dysfunction and the degree of pyramidal tract impairment as well as with the disability scores, as measured by Expanded Disability Status Scale (EDSS) (all p<0,001). Similarly, an association was found with the existence of lesions within the spinal cord in MRI (p=0,001). In group A, 90% of patients developed bacteriuria after SIC. Rates of bacteriuria in groups B and C were significantly lower (34% and 24% respectively, all p<0,001). Prophylaxis failed in 31% and 22% in group A and B patients respectively whereas all group C patients responded to prophylaxis. Symptomatic UTI was observed only in 14% of group A patients. Significant predictors of prophylaxis failure for both nitrofurantoin and norfloxacin were an EDSS score ≥ 6 (p=0.01 & p=0.05, respectively), high PVR (p=0.048 & p=0.075, respectively) and resistance of the pretreatment pathogen to the prophylaxis regimen (p<0.001 & p=0.007, respectively). The use of SIC did not have a significant association with prophylaxis failure either with nitrofurantoin (p=0.23) or with norfloxacin (p=0.103). In multivariate analysis only a higher EDSS score predicted prophylaxis failure overall (p=0.043).Conclusions: A significant proportion of MS patients with bladder dysfunction who used SIC developed asymptomatic bacteriuria. However, the overall proportion of UTIs was low. Antimicrobial prophylaxis with nitrofurantoin or norfloxacin eliminated bacteriuria more effectively in ambulatory patients (EDSS score < 6). Prior use of quinolones predicted prophylaxis failure with norfloxacin.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Fakas, Nikolaos
- Φάκας, Νικόλαος
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/40771